News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Kaiser Identifies and Ranks 10 Highest-Price Markets for Health Insurance and Determines that Lack of Competition Is One Contributing Factor

Pathologists may be surprised to learn that the nation’s highest-cost markets for health insurance include Colorado ski resorts and rural regions

What do the 10 most expensive U.S. health insurance markets have in common? According to a story published by Kaiser Health News, the 10 highest-priced markets are characterized by lack of competition among doctors, hospitals and insurers.

That will probably not be a surprise to most clinical laboratory managers and pathologists, particularly if they work for a health system that has lots of market clout in their community. That’s because concentration of market share by just a few powerful hospitals or health systems is associated with higher prices for healthcare. However, there are exceptions. (more…)

Illumina Asserts Its Claim of a $1,000 Whole Human Genome, But Is Gene Sequencing Ready for Use by Clinical Pathology Laboratories?

This price includes all costs except overhead, but without a high volume of customers, Illumina’s $10-million price for the HiSeq X Ten machine may not be a wise investment

Competition continues to be fierce in the race to the $1,000 whole human genome. Most recently, Illumina announced the availability of its latest gene sequencing system, along with the claim that it can deliver a whole human genome at a cost of just $1,000. But, as most pathologists know, the devil is in the details, since not every Illumina customer is likely to achieve that price point.

When Illumina, a San Diego-based technology company, announced its new HiSeq X Ten genetic-sequencing machine in December, 2013, Illumina CEO Jay T. Flatley claimed the company’s system can deliver “full-coverage human genome sequences for less than $1,000,” down from $500 million 10 years ago. The new system is expected to ship in the first quarter of 2014.

(more…)

Medical Tourism Continues to Flourish as U.S. Patients Seek Lower Cost Healthcare in Overseas Countries

Pathology groups and medical laboratories here in the United States still have few opportunities to provide reference or esoteric diagnostic services to healthcare providers in other countries

Despite the lack of publicity, medical tourism continues to enjoy vigorous growth as an increasing number of Americans prove willing to cross international borders to obtain healthcare that is considered of acceptable quality, but at a price that significantly cheaper than here in the United States.

What makes the trends in medical tourism relevant for clinical laboratory managers and pathologists is that it shows how U.S. consumers are reacting to high healthcare prices and other problems within the American healthcare system. In particular, our nation is experimenting with putting tens of millions of Americans in high-deductible health plans. How these consumers decide to price-shop because of their $3,000 to $10,000 per year individual and family deductibles remains to be seen. < (more…)

More Consolidation in the Clinical Laboratory Industry, as Quest Diagnostics Agrees to Pay $570 Million to Acquire Solstas Lab Partners

When completed, this acquisition will give Quest Diagnostics a major laboratory presence in the backyard of competitor Laboratory Corporation of America

Another big lab domino fell in the continuing consolidation of the clinical laboratory testing industry. This time it was Solstas Lab Partners, which announced that it would be acquired by Quest Diagnostics Incorporated (NYSE:DGX).

The agreement was announced by both companies earlier this week. Quest Diagnostics will pay $570 million to acquire Solstas, which is based in Greensboro, North Carolina. Solstas provides medical laboratory testing services to clients in nine states across the South. Quest Diagnostics says it expects to close the sale by the middle of this year, subject to the usual regulatory reviews of such transactions. (more…)

Consumers Turn to the Internet to Shop for Cheapest Prices Offered by Hospitals, Physicians, and Clinical Pathology Laboratories

Medibid.com is typical of new companies that help consumers identify providers with the best combination of low price and high quality

Should anyone be surprised that high insurance deductibles are motivating patients to shop for the best value on all sorts of healthcare services—including medical laboratory tests? One way consumers can shop for the lowest price is to utilize new web sites that allow providers to bid for the patient’s business!

Potential Business Opportunity for Clinical Labs and Pathology Groups

This new class of websites represents a business opportunity for clinical laboratory organizations and anatomic pathology groups. Essentially, these websites use real-time auctions to help consumers select the provider of their choice for all types of healthcare services, including medical laboratory tests. (more…)

PeaceHealth and University of Washington School of Medicine Form Strategic Alliance, Further Integrating Academic and Community Care Settings

There’s more consolidation in the hospital marketplace as institutions look to build scale and offer a fuller menu of healthcare services

Across the United States, multi-hospital health systems and stand-alone academic medical centers are looking for the right collaborations, alliances, and consolidation opportunities. This is happening because hospitals of all sizes and types recognize the need to be part of a comprehensive, integrated provider network in their region.

This is a trend that has ramifications for clinical laboratories and pathology groups that operate in the regions where these alliances and collaborations happen. That is because such collaborations can often change the competitive market for medical laboratory testing in the communities served by the partners in the alliance.
(more…)

;